Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Kieran Gallahue
Age : 57
Public asset : 5,197,044 USD
Country of residence : Unknown
Linked companies : Edwards Lifesciences Corporation - Envista Holdings Corporation

Biography of Kieran Gallahue 
Mr. Kieran T. Gallahue is an Independent Director at Envista Holdings Corp., an Independent Non-Executive Director at Arena Pharmaceuticals, Inc., a Chairman at Intersect ENT, Inc., an Independent Director at Edwards Lifesciences Corp. and a Chairman at Signifier Medical Technologies Ltd. He is on the Board of Directors at Envista Holdings Corp., Arena Pharmaceuticals, Inc., Edwards Lifesciences Corp., Nucleus Biologics LLC and Systems Oncology LLC. Mr. Gallahue was previously employed as a Chairman & Chief Executive Officer by CareFusion Corp., an Independent Director by Volcano Corp., a President, Chief Executive Officer, COO & Director by ResMed, Inc., a President & Chief Financial Officer by Nanogen, Inc., a Vice President-Critical Care Business Unit by Instrumentation Laboratory Co., a Principal by Procter & Gamble Co., and a Principal by General Electric Co. He also served on the board at Advanced Medical Technology Association. He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Harvard Business School.


Current positions of Kieran Gallahue 
Holdings of Kieran Gallahue 
Kieran Gallahue : Personal Network 
Most Read News 
11/20Buffett's Berkshire boosts stakes in Japan's five biggest trading houses
RE
12/01Salesforce shares tumble after surprise exit of co-CEO Taylor
RE
11/23Berkshire Hathaway says Warren Buffett donates shares to family charities
RE
11/30Meta's Zuckerberg says some of Elon Musk's Twitter content approach 'might work'
RE
11/30Juventus has no requirement of additional capital, says Exor's Elkann
RE
11/30Interpol confirms red notice for Angolan billionaire Isabel dos Santos
RE
11/18Musk's pay trial asks if Tesla's growth justifies $56 billion compensation
RE
11/22'Boomerang CEOs' don't always work out; Disney hopes this one bucks trend
RE
11/21Musk says Twitter to hold off relaunching blue check verification
RE
11/19Musk's Twitter poll showing narrow majority want Trump reinstated
RE
More news


© 2022 People and Ownership :   
Kieran Gallahue : Connections 


Latest news about Kieran Gallahue 
02/02Transcript : Arena Pharmaceuticals, Inc. - Shareholder/Analyst Call
CI
2021Transcript : Envista Holdings Corporation - Shareholder/Analyst Call
CI
2020Transcript : Arena Pharmaceuticals, Inc. - Shareholder/Analyst Call
CI
2020Transcript : Envista Holdings Corporation - Shareholder/Analyst Call
CI
2020Transcript : Edwards Lifesciences Corporation - Shareholder/Analyst Call
CI
2020Transcript : Intersect ENT, Inc., Q4 2019 Earnings Call, Feb 24, 2020
CI
2019Transcript : Intersect ENT, Inc., Q2 2019 Earnings Call, Aug 01, 2019
CI
More news